GSK and Fleming Initiative scientists unite to target AMR with advanced AI
Imperial wins Outstanding Entrepreneurial University at THE Awards
Imperial celebrates impact of supporters who gave £77.5 million in 2024-25
Our world-first centre focuses on the action and clinical use of psychedelics; exploring consciousness and treatments for mental health disorders
Find out more about our team members
Learn about our key research focus areas
Participate in an ongoing laboratory or survey study
Support our research and learn about our generous funders
Resources, media, and Centre FAQ
Contact the Centre for Psychedelic Research